[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2026.02.26.9855Pharm Sci Asia 2026; 53(2), 230-244
 

The impact of supply-side and demand-side cost-containment strategies on universal health coverage outcomes in Southeast Asian National Health Insurance Schemes: A systematic review

Nila Vidila Utami1, Dwi Endarti2*, Susi Ari Kristina2

1 Master Program in Management Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 Department of Pharmaceutics, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia


Southeast Asia's rapid growth of Universal Health Coverage (UHC) is increasingly hampered by growing healthcare costs and financial constraints. Although cost-containment instruments are widely implemented, their systemic trade-offs—particularly regarding health equity and service quality—remain poorly understood across the region's diverse health systems. This systematic review synthesizes empirical evidence on the effectiveness of supply-side and demand-side cost-containment instruments across five UHC outcome domains (financial protection, access, equity, quality, and efficiency) in Southeast Asian National Health Insurance schemes. Following PRISMA 2020 guidelines, we systematically searched Scopus and PubMed from inception to December 2025. Of 362 records, 21 empirical studies from five countries (Thailand, Indonesia, Vietnam, Philippines, Lao PDR) met inclusion criteria. Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT). Evidence reveals a sharp divergence in policy performance. Synergistic strategic purchasing—exemplified by Thailand's integrated capitation, global budgets, and central procurement—achieved significant pro-poor equity (27–30% of subsidies concentrated in the poorest quintile) and 25% savings in pharmaceutical expenditures. Conversely, fragmented instruments in other settings triggered adverse provider behaviors, including cost-shifting to patients, induced utilization, and potential quality concerns. Even in relatively high-performing schemes, persistent inequities related to geography, gender, and chronic disease management remain unresolved. Cost-containment effectiveness depends fundamentally on governance maturity and policy integration, not technical design alone. To safeguard UHC sustainability, Southeast Asian policymakers should transition from fragmented cost-cutting toward data-driven, quality-linked strategic purchasing frameworks that actively monitor equity and outcomes.


Keyword:

Cost control; Universal Health Coverage; Health equity; Health financing; Southeast Asia




Download full paper (PDF File size: 1,016.90 KB.)





Vol.53
No.2
April-June 2026

See other volume

 


Vol.53
No.1
January-March 2026

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2026
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.